Principal Securities »

Edgewise Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $720 27 26.70

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Principal Exchange Traded Prin U S Small (PSC)
Microsoft Corporation (MSFT)
Principal Exchange Traded Focused Blue Chi (BCHP)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Principal Securities

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Novo A/S
Vanguard Group
Cormorant Asset Management
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Henderson Group
Perceptive Advisors
TCG Crossover Management
Braidwell
Driehaus Capital Management

View all funds holding Edgewise Therapeutics